Rheinmetall's Order Book Is Full — Its Calendar Is the Problem

Rheinmetall entered November with a bulging backlog and a shrinking set of promises. The defence group's first nine months of 2026 delivered the kind of growth most industrials can only dream of, yet management trimmed its full-year outlook — a pairing that has forced investors to ask a more uncomfortable question than whether demand exists. It is whether the company can convert orders into revenue on schedule.

The scale of the delivery is not in doubt. Revenue for the January-to-September period climbed 38% year on year to EUR 8.4 billion, while operating profit jumped 69% to EUR 1.34 billion, good for a 16.0% operating margin. What followed those numbers was the surprise: Rheinmetall now guides to roughly EUR 13.2 billion in sales for the full year, down from an earlier range of EUR 13.7–14.2 billion. The margin target was pared to about 18.5% from around 19%.

Boxer and artillery lots behind the cut

Management pinned the revision on two bottlenecks: delayed contracting on the Boxer project Arminius and slower lot acceptances for artillery ammunition. Neither points to vanished demand — both point to timing. That distinction matters, because Rheinmetall's order book stood at EUR 78.0 billion as of 30 September 2026. A backlog of that size and a softer annual forecast are not contradictory; they simply describe a business whose potential is not the same thing as its punctual realisation.

The brokerages responded within days, and their moves tell their own story about where the debate now sits. Berenberg cut its price target to EUR 900 from EUR 1,020 on Tuesday while keeping a Hold rating, with analyst George McWhirter expecting Rheinmetall to lower its longer-term revenue goals at the upcoming capital markets day — an expectation, not a decision the company has announced. Citi trimmed its target to EUR 1,099 the following day, keeping a Buy rating and citing the same anticipated mid-term guidance adjustment. The shares slipped 0.8% in the session before that note.

A Belgian contract and a harder question

Not every data point leans negative. On 9 November Rheinmetall secured a Belgian order for 20 Skyranger 30 systems; the procurement package, logistics included, carries a value in the mid-three-digit millions of euros, with deliveries slated to begin at the end of 2028. It is a concrete win — and also a reminder of the gap between signing and shipping. New business can strengthen the long-term base without plugging a near-term hole, and anyone betting on a recovery has to hold both effects in view at once.

BofA Securities framed the risk more broadly. On 9 November it downgraded Rheinmetall from Buy to Neutral and slashed its target to EUR 900 from EUR 1,300, pointing to lower growth expectations for armoured vehicles and artillery ammunition alongside the project delays and customer acceptances. That is a heavier charge than a mere scheduling slip: weaker expected growth would undercut the foundation of longer-range planning, and a large backlog does not by itself refute it.

Two distinct risks therefore need separating. If revenue merely arrives later, the timetable is what's in question. If the growth opportunity itself is smaller, expectations for future business volume must come down too. In the second scenario, fresh individual orders would not be enough to restore confidence; they would have to fit a credible overall plan, or investors may welcome each win while assigning it less weight in their valuations.

What Hamburg must deliver

The next hard catalyst is the capital markets day, scheduled for 26–27 November 2026 according to the investor relations calendar. Rheinmetall has said it will offer more detailed commentary there on the following year and on its medium-term targets. Mid-term goals and the operational underpinning behind them are likely to draw the closest scrutiny.

For shareholders, a demonstrable link between order intake, delivery scheduling and revenue would carry more weight than any standalone target. Only that chain will show whether the recent disappointments are chiefly a matter of calendar — or whether the market needs to adopt a fundamentally more cautious view of how fast this business can grow.